Joseph K Belanoff

Chief Executive Officer · Corcept Therapeutics

Joseph K Belanoff (Chief Executive Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Corcept Therapeutics Incorporated (CORT). The largest single filing was $3.2M of CORT (40,000 sh × $79.77, as filed), executed Dec 1 2025. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$7.4M

shares × price, as filed

Last traded

Jun 1

Filed Jun 2

Median ADV $130.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $29.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

CORT

Corcept Therapeutics Incorporated CORT · 0 buys · 13 sells 13 filings

Recent filings

CORTSALE Corcept Therapeutics Incorporated View filing → $895K
12,837 sh × $69.74
Exec Jun 1
Filed Jun 2 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $2.0M
40,000 sh × $50.10
Exec May 1
Filed May 5 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $1.3M
26,198 sh × $50.07
Exec Mar 25
Filed Mar 27 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $3.2M
40,000 sh × $79.77
Exec Dec 1 2025
Filed Dec 3 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $3.0M
40,000 sh across 4 lots
Exec Nov 3 2025
Filed Nov 5 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $3.4M
40,000 sh across 3 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $2.8M
39,300 sh × $70.52
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET CORTSALE Corcept Therapeutics Incorporated View filing → $2.7M
40,000 sh across 3 lots
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET More filings →